

The FDA Rejects MDMA-Assisted Therapy
Aug 28, 2024
Dr. Dave Rabin, a leading medical professional, joins retired army sergeant Jon Lubecky, who participated in MAPS MDMA therapy trials, to discuss the FDA's recent rejection of MDMA-assisted therapy. They delve into the implications of this decision and its impact on veterans seeking help. Unethical behavior from organizations like Symposia, including falsifying information, raises serious ethical concerns. The conversation emphasizes the urgent need for continued advocacy, transparency, and hope for future access to these transformative treatments.
Chapters
Transcript
Episode notes
1 2 3 4 5 6
Intro
00:00 • 2min
FDA's Rejection of MDMA Therapy: Implications and Advocacy
02:26 • 21min
Struggles and Resilience in the Face of Adversity
23:20 • 3min
Exploring MDMA Therapy and Ethical Concerns in Mental Health Research
26:30 • 4min
Moral Relativism and Healing Access
30:57 • 8min
Emphasizing Shared Humanity in Mental Health Challenges
38:30 • 2min